Mylan Laboratories to start roadshow Wednesday for $500 million two-part deal

By Paul A. Harris

St. Louis, July 5 - Mylan Laboratories Inc. will start a roadshow Wednesday for its $500 million two-part offering of senior notes (Ba1/BB+), according to a syndicate source.

An investor call is scheduled for 12:30 p.m. ET Thursday. Pricing is expected on July 14.

The Canonsburg, Pa., pharmaceutical company is in the market with a five-year bullet and a 10-year note which comes with five years of call protection.

Merrill Lynch & Co. has the books for the Rule 144A/Regulation S offering. BNY Securities, KeyBanc, PNC and SunTrust Robinson Humphrey are the co-managers.

Proceeds, along with on hand cash, will be used to fund a $1.25 billion share repurchase program.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.